[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336913-105":59,"doc-detail-336913-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-slc31a1-as-a-prognostic-biomarker-and-a-target-for-therapeutics-in-breast-cancer","Identification of SLC31A1 as a prognostic biomarker and a target for therapeutics in breast cancer","","Copper-induced cell death is regulated by protein lipoylation, yet the involvement of Cuproptosis-related genes in breast cancer remains unclear. This study built a prognostic signature from Cuproptosis-related gene expression to support BC diagnosis and treatment. Data from TCGA, GTEx, and GEO (GSE65212) were analyzed using 19 Cuproptosis-related genes and in silico immune and survival assessments. Experimental validation in vitro and in vivo focused on SLC31A1, linking high expression to poor prognosis, immune infiltration changes, and reduced tumor cell aggressiveness after knockdown.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-slc31a1-as-a-prognostic-biomarker-and-a-target-for-therapeutics-in-breast-cancer/336913/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-slc31a1-as-a-prognostic-biomarker-and-a-target-for-therapeutics-in-breast-cancer/336913.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the study regarding SLC31A1 in breast cancer?","Question",{"text":112,"@type":113},"To identify SLC31A1 as a prognostic biomarker and a potential therapeutic target by constructing and validating Cuproptosis-related prognostic models for breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the prognostic signature for breast cancer developed?",{"text":117,"@type":113},"The signature was built using expression of Cuproptosis-related genes and evaluated with nineteen Cuproptosis-related genes across BC tissues and normal breast tissues from TCGA, GTEx, and GEO GSE65212.",{"name":119,"@type":110,"acceptedAnswer":120},"What key experimental evidence supports the role of SLC31A1?",{"text":121,"@type":113},"In vitro assays and in vivo mouse experiments showed that SLC31A1 knockdown reduced proliferation, migration, and invasiveness of Her2+ enriched breast cancer cells and decreased tumor volume in the mouse model.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336913,1790186539,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification of SLC31A1 as a prognostic biomarker and a target for therapeutics in breast cancer  \nHongtao Fu1,2, Shanshan Dong3 & Kun Li4􀀍  \nCopper-induced cell death is regulated through protein lipoylation, which is critical for gene expression and phenotypic regulation. Neverless, the role ofCuproptosis-related genes in breast cancer (BC) remains unknown. This study aimed to construct a prognostic signature based on the expression of Cuproptosis-related genes in order to guide the diagnosis and treatment for BC. Cuproptosis-related genes prognostic signature has ata of 1250 BC tissues and 583 normal breast tissues were obtained from The Cancer Genome Atlas (TCGA), Genotype Tissue Expression (GTEx), and GEO GSE65212. The prognostic signature was established and evaluated with nineteen Cuproptosis-related genes. A series of in silico analyses based on SLC31A1, included expression analysis, independent prognostic analysis, correlation analysis, immune-related analysis and survival analysis. Finally, a series of cell experiments (including quantitative real-time polymerase chain reaction and western blot), and mice experiments were applied to evaluate the impact ofSLC31A1 on BC. Cuproptosis-related genes prognostic signature has good predictive promising for survival in BC patients. We discovered that SLC31A1SLC31A1 was overexpressed in BC and was its independent prognostic factor. High expression of the SLC31A1 was correlated with poor prognosis and immune infiltrating of BC. SLC31A1 expression is associated with immune, chemotherapeutic and targeted therapy outcomes in BC. The proliferation, migration, and invasiveness of Her2 +enriched BC cells were decreased by SLC31A1 knockdown, also resulting in a decrease in tumor volume in mouse model. SLC31A1 is a candidate biomarker or therapeutic target in precision oncology, with diagnostic and prognostic significance in BC.  \nKeywords Cuproptosis-related genes, Bioinformatics analysis, Biomarker, Breast cancer  \nAbbreviations  \nBC Breast cancer  \nKM Kaplan–Meier  \nIDC Infiltrating Ductal Carcinoma  \nOS Overall survival  \nTHPA The Human Protein Atlas TCGA The Cancer Genome Atlas GTEx Genotype Tissue Expression GEO Gene Expression Omnibus PPI Protein-protein interaction  \nGO Gene Ontology  \nKEGG Kyoto Encyclopedia of Genes and Genomes DE Differentially expressed  \nCTL Cytotoxic T-cell levels  \nTIDE Tumor Immune Dysfunction and Exclusion ICB Immune checkpoint blockade  \n1Department of Breast Surgery, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410006, Hunan, China. 2Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210000, China. 3Department of Medicine, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410000, China. 4Department of Emergency Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, 161 Shaoshan South Road, Changsha 410000, China. 􀀍 email: [kunli666003@163.com](kunli666003@163.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nNew and noteworthy  \nCopper-induced cell death is mediated mechanism by protein lipoylation, plays an important role in regulating gene expression and phenotype. Our results systematically demonstrated the expression and prognostic value of Cuproptosis-related genes in breast cancer and its key gene SLC31A1SLC31A1 to guide diagnosis and treatment for breast cancer. We evidenced through a series of crucial in vivo and in vitro investigations that SLC31A1 has a significant impact on the promotion of Her2 +enriched breast cancer cells.  \nBackground  \nBreast cancer (BC) is one of the leading causes of mortality in women throughout the world1. Despite great progress in diagnosis, treatment and prognosi","cbCaihAkriGVeRB4","https://ap.wps.com/l/cbCaihAkriGVeRB4","pdf",5192846,18,"English","# New and noteworthy\n# Background\n# Copper and Cuproptosis-related genes in breast cancer","[{\"question\":\"What is the purpose of the study regarding SLC31A1 in breast cancer?\",\"answer\":\"To identify SLC31A1 as a prognostic biomarker and a potential therapeutic target by constructing and validating Cuproptosis-related prognostic models for breast cancer.\"},{\"question\":\"How was the prognostic signature for breast cancer developed?\",\"answer\":\"The signature was built using expression of Cuproptosis-related genes and evaluated with nineteen Cuproptosis-related genes across BC tissues and normal breast tissues from TCGA, GTEx, and GEO GSE65212.\"},{\"question\":\"What key experimental evidence supports the role of SLC31A1?\",\"answer\":\"In vitro assays and in vivo mouse experiments showed that SLC31A1 knockdown reduced proliferation, migration, and invasiveness of Her2+ enriched breast cancer cells and decreased tumor volume in the mouse model.\"}]","Identification of SLC31A1 as a prognostic biomarker and a target for therapeutics in breast cancer | PDF",1790017040,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b64fd63b625a43e71cfd146ff12aa776.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3c55173345c6c13d1376f0b8629f0d7.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f59ddde30634d90722b76bdd04aee5ab.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37f8c51a8a9beaac7d63bca276df4f59.webp",980,1287]